CHEK1 in breast cancer is also a notable regulator of the response to DNA damage, which is over-expressed in triple-negative breast cancer (TNBC) and has therefore been proposed as a potential target for treatment [51]. The gene discussed is CHEK1; the disease is breast cancer.